Evidence-Based Medicine Guidelines
Antioxidant treatment for amyotrophic lateral sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antioxidant Treatment for Amyotrophic Lateral Sclerosis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis.
Antioxidant treatment for amyotrophic lateral sclerosis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis. Accessed July 28, 2025.
Antioxidant treatment for amyotrophic lateral sclerosis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis
Antioxidant Treatment for Amyotrophic Lateral Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 July 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antioxidant treatment for amyotrophic lateral sclerosis
ID - 455370
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
